Computational immune synapse analysis reveals T-cell interactions in distinct tumor microenvironments
暂无分享,去创建一个
Jeffrey H. Chuang | Jie Zhou | K. Palucka | J. Martinek | Victor G. Wang | Hannah Boruchov | Zichao Liu | Kelly Ray
[1] T. Sheikh,et al. Melanoma Treatments and Mortality Rate Trends in the US, 1975 to 2019 , 2022, JAMA network open.
[2] Nils Eling,et al. Multiplexed imaging mass cytometry of the chemokine milieus in melanoma characterizes features of the response to immunotherapy , 2022, Science Immunology.
[3] H. Najafabadi,et al. Spatially mapping the immune landscape of melanoma using imaging mass cytometry , 2022, Science Immunology.
[4] S. Tavaré,et al. Three-dimensional imaging mass cytometry for highly multiplexed molecular and cellular mapping of tissues and the tumor microenvironment , 2021, Nature Cancer.
[5] Ansuman T. Satpathy,et al. Spatiotemporal co-dependency between macrophages and exhausted CD8+ T cells in cancer , 2021, bioRxiv.
[6] Rob J. de Boer,et al. Cytotoxic T cells are able to efficiently eliminate cancer cells by additive cytotoxicity , 2021, Nature Communications.
[7] D. Bending,et al. Antigen and checkpoint receptor engagement recalibrates T cell receptor signal strength , 2021, Immunity.
[8] Jeffrey H. Chuang,et al. Transcriptional profiling of macrophages in situ in metastatic melanoma reveals localization-dependent phenotypes and function , 2021, Cell reports. Medicine.
[9] K. Rogers,et al. Spatial omics and multiplexed imaging to explore cancer biology , 2021, Nature Methods.
[10] Alyce A. Chen,et al. The Spatial Landscape of Progression and Immunoediting in Primary Melanoma at Single-Cell Resolution , 2021, bioRxiv.
[11] Tyler T. Risom,et al. Whole-cell segmentation of tissue images with human-level performance using large-scale data annotation and deep learning , 2021, Nature Biotechnology.
[12] D. Rimm,et al. Biomarker Discovery in Patients with Immunotherapy-Treated Melanoma with Imaging Mass Cytometry , 2021, Clinical Cancer Research.
[13] Xiongtao Ruan,et al. PD-1 suppresses the maintenance of cell couples between cytotoxic T cells and target tumor cells within the tumor , 2020, Science Signaling.
[14] Salil S. Bhate,et al. Coordinated Cellular Neighborhoods Orchestrate Antitumoral Immunity at the Colorectal Cancer Invasive Front , 2020, Cell.
[15] Reem Saleh,et al. FoxP3+ T regulatory cells in cancer: Prognostic biomarkers and therapeutic targets. , 2020, Cancer letters.
[16] M. Lenardo,et al. A guide to cancer immunotherapy: from T cell basic science to clinical practice , 2020, Nature Reviews Immunology.
[17] Zhaolin Hua,et al. The role of B cell antigen presentation in the initiation of CD4+ T cell response , 2020, Immunological reviews.
[18] Roger R. Wang,et al. Multi-panel immunofluorescence analysis of tumor infiltrating lymphocytes in triple negative breast cancer: Evolution of tumor immune profiles and patient prognosis , 2020, PloS one.
[19] Marius Pachitariu,et al. Cellpose: a generalist algorithm for cellular segmentation , 2020, Nature Methods.
[20] I. A. Adejumobi,et al. Dissecting the role of crosstalk between glioblastoma subpopulations in tumor cell spreading , 2020, Oncogenesis.
[21] Carlos Caldas,et al. Imaging mass cytometry and multiplatform genomics define the phenogenomic landscape of breast cancer , 2020, Nature Cancer.
[22] H. Moch,et al. The single-cell pathology landscape of breast cancer , 2020, Nature.
[23] Jeffrey E. Lee,et al. B cells and tertiary lymphoid structures promote immunotherapy response , 2020, Nature.
[24] D. Schadendorf,et al. Tertiary lymphoid structures improve immunotherapy and survival in melanoma , 2020, Nature.
[25] Shixiang Wang,et al. Antigen presentation and tumor immunogenicity in cancer immunotherapy response prediction , 2019, eLife.
[26] S. Hilsenbeck,et al. Evaluation of the Predictive Role of Tumor Immune Infiltrate in Patients with HER2-Positive Breast Cancer Treated with Neoadjuvant Anti-HER2 Therapy without Chemotherapy , 2019, Clinical Cancer Research.
[27] Maxim N. Artyomov,et al. MHC-II neoantigens shape tumor immunity and response to immunotherapy , 2019, Nature.
[28] D. Pe’er,et al. Combination anti–CTLA-4 plus anti–PD-1 checkpoint blockade utilizes cellular mechanisms partially distinct from monotherapies , 2019, Proceedings of the National Academy of Sciences.
[29] J. Wilmott,et al. Close proximity of immune and tumor cells underlies response to anti-PD-1 based therapies in metastatic melanoma patients , 2019, Oncoimmunology.
[30] Fred A. Hamprecht,et al. ilastik: interactive machine learning for (bio)image analysis , 2019, Nature Methods.
[31] Salil S. Bhate,et al. Coordinated Cellular Neighborhoods Orchestrate Antitumoral Immunity at the Colorectal Cancer Invasive Front , 2019, Cell.
[32] J. Madore,et al. Distinct Immune Cell Populations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1/Anti-CTLA-4 Combined Therapy. , 2019, Cancer cell.
[33] Aviv Regev,et al. Checkpoint Blockade Immunotherapy Induces Dynamic Changes in PD‐1−CD8+ Tumor‐Infiltrating T Cells , 2019, Immunity.
[34] Johannes Griss,et al. B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma , 2019, Nature Communications.
[35] Timothy A. Chan,et al. The hallmarks of successful anticancer immunotherapy , 2018, Science Translational Medicine.
[36] Sean C. Bendall,et al. A Structured Tumor-Immune Microenvironment in Triple Negative Breast Cancer Revealed by Multiplexed Ion Beam Imaging , 2018, Cell.
[37] P. Darcy,et al. Multiplex immunohistochemistry accurately defines the immune context of metastatic melanoma , 2018, Scientific Reports.
[38] V. Pascual,et al. IL1 Receptor Antagonist Controls Transcriptional Signature of Inflammation in Patients with Metastatic Breast Cancer. , 2018, Cancer research.
[39] Eugene W. Myers,et al. Cell Detection with Star-convex Polygons , 2018, MICCAI.
[40] Sandro Santagata,et al. Highly multiplexed immunofluorescence imaging of human tissues and tumors using t-CyCIF and conventional optical microscopes , 2018, eLife.
[41] Steven J. M. Jones,et al. The Immune Landscape of Cancer , 2018, Immunity.
[42] C. Baldari,et al. Signals Controlling Lytic Granule Polarization at the Cytotoxic Immune Synapse , 2018, Front. Immunol..
[43] J. Banchereau,et al. Humanized mice in studying efficacy and mechanisms of PD-1-targeted cancer immunotherapy , 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[44] Sarah A. Teichmann,et al. Faculty Opinions recommendation of histoCAT: analysis of cell phenotypes and interactions in multiplex image cytometry data. , 2017 .
[45] J. Madrigal,et al. B cell regulation in cancer and anti-tumor immunity , 2017, Cellular &Molecular Immunology.
[46] Theresa A. Storm,et al. Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors , 2017, Science Translational Medicine.
[47] I. Mellman,et al. Elements of cancer immunity and the cancer–immune set point , 2017, Nature.
[48] I. Weissman,et al. First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[49] G. Nolan,et al. Automated Mapping of Phenotype Space with Single-Cell Data , 2016, Nature Methods.
[50] M. Vicente-Manzanares,et al. Concerning immune synapses: a spatiotemporal timeline , 2016, F1000Research.
[51] Lisa M. Coussens,et al. The Basis of Oncoimmunology , 2016, Cell.
[52] yang-xin fu,et al. CD47 Blockade Triggers T cell-mediated Destruction of Immunogenic Tumors , 2015, Nature Medicine.
[53] D. Fearon,et al. T cell exclusion, immune privilege, and the tumor microenvironment , 2015, Science.
[54] Emmanuelle Gouillart,et al. scikit-image: image processing in Python , 2014, PeerJ.
[55] F. Schuetz,et al. B cell-regulated immune responses in tumor models and cancer patients , 2013, Oncoimmunology.
[56] Michael Y. Gerner,et al. Histo-cytometry: a method for highly multiplex quantitative tissue imaging analysis applied to dendritic cell subset microanatomy in lymph nodes. , 2012, Immunity.
[57] Takashi Saito,et al. Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2 , 2012, The Journal of experimental medicine.
[58] I. Weissman,et al. Anti-CD47 antibodies promote phagocytosis and inhibit the growth of human myeloma cells , 2012, Leukemia.
[59] I. Ellis,et al. The prognostic significance of B lymphocytes in invasive carcinoma of the breast , 2012, Breast Cancer Research and Treatment.
[60] C. Sautès-Fridman,et al. The immune contexture in human tumours: impact on clinical outcome , 2012, Nature Reviews Cancer.
[61] P. Sharma,et al. The ICOS/ICOSL pathway is required for optimal antitumor responses mediated by anti-CTLA-4 therapy. , 2011, Cancer research.
[62] J. Tímár,et al. Prognostic impact of B-cell density in cutaneous melanoma , 2011, Cancer Immunology, Immunotherapy.
[63] Gaël Varoquaux,et al. Scikit-learn: Machine Learning in Python , 2011, J. Mach. Learn. Res..
[64] Ash A. Alizadeh,et al. Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma , 2010, Cell.
[65] T. Tedder,et al. B Cells Are Required for Optimal CD4+ and CD8+ T Cell Tumor Immunity: Therapeutic B Cell Depletion Enhances B16 Melanoma Growth in Mice , 2010, The Journal of Immunology.
[66] Jian Yu,et al. Otsu Method and K-means , 2009, 2009 Ninth International Conference on Hybrid Intelligent Systems.
[67] M. Herrero,et al. Infiltrating CTLs in human glioblastoma establish immunological synapses with tumorigenic cells. , 2009, The American journal of pathology.
[68] Michael Loran Dustin. T‐cell activation through immunological synapses and kinapses , 2008, Immunological reviews.
[69] J. Houghton,et al. Tumor microenvironment: The role of the tumor stroma in cancer , 2007, Journal of cellular biochemistry.
[70] Anne E Carpenter,et al. CellProfiler: image analysis software for identifying and quantifying cell phenotypes , 2006, Genome Biology.
[71] J. Joyce,et al. Therapeutic Targeting of the Tumor Microenvironment. , 2021, Cancer discovery.
[72] Mark M. Davis,et al. T-cell-antigen recognition and the immunological synapse , 2003, Nature Reviews Immunology.
[73] G. Griffiths,et al. The immunological synapse of CTL contains a secretory domain and membrane bridges. , 2001, Immunity.
[74] M. Sadelain,et al. Antigen-dependent CD28 Signaling Selectively Enhances Survival and Proliferation in Genetically Modified Activated Human Primary T Lymphocytes , 1998, The Journal of experimental medicine.
[75] E. M.,et al. Statistical Mechanics , 2021, Manual for Theoretical Chemistry.
[76] Sebastian Amigorena,et al. Dissecting the Tumor Myeloid Compartment Reveals Rare Activating Antigen-Presenting Cells Critical for T Cell Immunity. , 2014, Cancer cell.